MedTrace Logo

ST Segment Detection Study

NCT00930969 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2019-02-18

Study results available
· View outcomes & findings →

Summary

The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) who have coronary artery disease.

Conditions

Interventions

DEVICE

ICD

Subjects implanted with an ICD.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • George Crossley, MD · St. Thomas Research Institute and University of Tennessee College of Medicine Nashville, TN

  • Timothy Henry, MD · Minneapolis Heart Institute Foundation Minneapolis, MN

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-11-30
Completion
2011-03-31

Countries

  • United States
  • Austria
  • Belgium
  • Denmark
  • Germany
  • Netherlands
  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00930969 on ClinicalTrials.gov